vs
Side-by-side financial comparison of APTARGROUP, INC. (ATR) and DONALDSON Co INC (DCI). Click either name above to swap in a different company.
APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $935.4M, roughly 1.0× DONALDSON Co INC). DONALDSON Co INC runs the higher net margin — 12.2% vs 7.7%, a 4.5% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs 3.9%). DONALDSON Co INC produced more free cash flow last quarter ($111.2M vs $96.9M). Over the past eight quarters, DONALDSON Co INC's revenue compounded faster (3.3% CAGR vs 2.6%).
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
Donaldson Company, Inc. is a filtration company engaged in the production and marketing of filtration products used in a variety of industry sectors, including commercial/industrial, aerospace, chemical, alternative energy (windmills), food & beverage, and pharmaceuticals. Also the company's research division, located in Minneapolis, Minn., participated in defense-related projects for various military applications.
ATR vs DCI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $962.7M | $935.4M |
| Net Profit | $74.3M | $113.9M |
| Gross Margin | — | 35.2% |
| Operating Margin | 11.0% | 16.0% |
| Net Margin | 7.7% | 12.2% |
| Revenue YoY | 13.5% | 3.9% |
| Net Profit YoY | -26.4% | 15.1% |
| EPS (diluted) | $1.13 | $0.97 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $962.7M | $935.4M | ||
| Q3 25 | $961.1M | $980.7M | ||
| Q2 25 | $966.0M | $940.1M | ||
| Q1 25 | $887.3M | $870.0M | ||
| Q4 24 | $848.1M | $900.1M | ||
| Q3 24 | $909.3M | $935.4M | ||
| Q2 24 | $910.1M | $927.9M | ||
| Q1 24 | $915.4M | $876.7M |
| Q4 25 | $74.3M | $113.9M | ||
| Q3 25 | $127.9M | $114.3M | ||
| Q2 25 | $111.7M | $57.8M | ||
| Q1 25 | $78.8M | $95.9M | ||
| Q4 24 | $100.9M | $99.0M | ||
| Q3 24 | $100.0M | $109.7M | ||
| Q2 24 | $90.5M | $113.5M | ||
| Q1 24 | $83.1M | $98.7M |
| Q4 25 | — | 35.2% | ||
| Q3 25 | — | 34.5% | ||
| Q2 25 | — | 34.2% | ||
| Q1 25 | — | 35.2% | ||
| Q4 24 | — | 35.5% | ||
| Q3 24 | — | 35.8% | ||
| Q2 24 | — | 35.6% | ||
| Q1 24 | — | 35.2% |
| Q4 25 | 11.0% | 16.0% | ||
| Q3 25 | 14.2% | 15.5% | ||
| Q2 25 | 14.9% | 9.3% | ||
| Q1 25 | 12.8% | 14.4% | ||
| Q4 24 | 14.2% | 14.5% | ||
| Q3 24 | 15.2% | 15.6% | ||
| Q2 24 | 13.8% | 15.5% | ||
| Q1 24 | 12.2% | 14.8% |
| Q4 25 | 7.7% | 12.2% | ||
| Q3 25 | 13.3% | 11.7% | ||
| Q2 25 | 11.6% | 6.1% | ||
| Q1 25 | 8.9% | 11.0% | ||
| Q4 24 | 11.9% | 11.0% | ||
| Q3 24 | 11.0% | 11.7% | ||
| Q2 24 | 9.9% | 12.2% | ||
| Q1 24 | 9.1% | 11.3% |
| Q4 25 | $1.13 | $0.97 | ||
| Q3 25 | $1.92 | $0.97 | ||
| Q2 25 | $1.67 | $0.48 | ||
| Q1 25 | $1.17 | $0.79 | ||
| Q4 24 | $1.48 | $0.81 | ||
| Q3 24 | $1.48 | $0.90 | ||
| Q2 24 | $1.34 | $0.92 | ||
| Q1 24 | $1.23 | $0.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $409.5M | $210.7M |
| Total DebtLower is stronger | $1.1B | $671.5M |
| Stockholders' EquityBook value | $2.7B | $1.5B |
| Total Assets | $5.3B | $3.0B |
| Debt / EquityLower = less leverage | 0.43× | 0.44× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $409.5M | $210.7M | ||
| Q3 25 | $264.8M | $180.4M | ||
| Q2 25 | $169.8M | $178.5M | ||
| Q1 25 | $136.8M | $189.1M | ||
| Q4 24 | $226.2M | $221.2M | ||
| Q3 24 | $327.9M | $232.7M | ||
| Q2 24 | $223.9M | $223.7M | ||
| Q1 24 | $201.1M | $193.8M |
| Q4 25 | $1.1B | $671.5M | ||
| Q3 25 | $546.0M | $630.4M | ||
| Q2 25 | $535.1M | $638.8M | ||
| Q1 25 | $561.2M | $514.7M | ||
| Q4 24 | $688.1M | $538.6M | ||
| Q3 24 | $822.7M | $483.4M | ||
| Q2 24 | $681.5M | $481.8M | ||
| Q1 24 | $680.4M | $352.0M |
| Q4 25 | $2.7B | $1.5B | ||
| Q3 25 | $2.8B | $1.5B | ||
| Q2 25 | $2.7B | $1.5B | ||
| Q1 25 | $2.5B | $1.5B | ||
| Q4 24 | $2.5B | $1.5B | ||
| Q3 24 | $2.5B | $1.5B | ||
| Q2 24 | $2.4B | $1.5B | ||
| Q1 24 | $2.3B | $1.4B |
| Q4 25 | $5.3B | $3.0B | ||
| Q3 25 | $5.1B | $3.0B | ||
| Q2 25 | $4.9B | $3.0B | ||
| Q1 25 | $4.5B | $3.0B | ||
| Q4 24 | $4.4B | $3.0B | ||
| Q3 24 | $4.6B | $2.9B | ||
| Q2 24 | $4.5B | $2.9B | ||
| Q1 24 | $4.4B | $2.8B |
| Q4 25 | 0.43× | 0.44× | ||
| Q3 25 | 0.20× | 0.43× | ||
| Q2 25 | 0.20× | 0.44× | ||
| Q1 25 | 0.22× | 0.33× | ||
| Q4 24 | 0.28× | 0.35× | ||
| Q3 24 | 0.32× | 0.32× | ||
| Q2 24 | 0.28× | 0.32× | ||
| Q1 24 | 0.29× | 0.26× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.7M | $125.4M |
| Free Cash FlowOCF − Capex | $96.9M | $111.2M |
| FCF MarginFCF / Revenue | 10.1% | 11.9% |
| Capex IntensityCapex / Revenue | 9.0% | 1.5% |
| Cash ConversionOCF / Net Profit | 2.47× | 1.10× |
| TTM Free Cash FlowTrailing 4 quarters | $299.6M | $403.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $183.7M | $125.4M | ||
| Q3 25 | $177.6M | $167.8M | ||
| Q2 25 | $126.0M | $87.7M | ||
| Q1 25 | $82.7M | $90.4M | ||
| Q4 24 | $178.2M | $72.9M | ||
| Q3 24 | $229.3M | $126.0M | ||
| Q2 24 | $143.6M | $141.5M | ||
| Q1 24 | $92.3M | $87.0M |
| Q4 25 | $96.9M | $111.2M | ||
| Q3 25 | $114.3M | $147.5M | ||
| Q2 25 | $62.5M | $73.0M | ||
| Q1 25 | $25.9M | $71.5M | ||
| Q4 24 | $112.2M | $47.9M | ||
| Q3 24 | $162.7M | $106.2M | ||
| Q2 24 | $75.4M | $120.2M | ||
| Q1 24 | $16.7M | $65.7M |
| Q4 25 | 10.1% | 11.9% | ||
| Q3 25 | 11.9% | 15.0% | ||
| Q2 25 | 6.5% | 7.8% | ||
| Q1 25 | 2.9% | 8.2% | ||
| Q4 24 | 13.2% | 5.3% | ||
| Q3 24 | 17.9% | 11.4% | ||
| Q2 24 | 8.3% | 13.0% | ||
| Q1 24 | 1.8% | 7.5% |
| Q4 25 | 9.0% | 1.5% | ||
| Q3 25 | 6.6% | 2.1% | ||
| Q2 25 | 6.6% | 1.6% | ||
| Q1 25 | 6.4% | 2.2% | ||
| Q4 24 | 7.8% | 2.8% | ||
| Q3 24 | 7.3% | 2.1% | ||
| Q2 24 | 7.5% | 2.3% | ||
| Q1 24 | 8.3% | 2.4% |
| Q4 25 | 2.47× | 1.10× | ||
| Q3 25 | 1.39× | 1.47× | ||
| Q2 25 | 1.13× | 1.52× | ||
| Q1 25 | 1.05× | 0.94× | ||
| Q4 24 | 1.77× | 0.74× | ||
| Q3 24 | 2.29× | 1.15× | ||
| Q2 24 | 1.59× | 1.25× | ||
| Q1 24 | 1.11× | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
DCI
| Aftermarket Products | $447.1M | 48% |
| Industrial Filtration Solutions Products | $222.6M | 24% |
| Off Road Products | $86.5M | 9% |
| Life Sciences Segment | $80.0M | 9% |
| Other | $39.1M | 4% |
| Aerospace And Defense Products | $37.1M | 4% |
| On Road Products | $23.0M | 2% |
